Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
AUTOR(ES)
Sutherland, Robert L
FONTE
BioMed Central
RESUMO
Cyclin D1 is one of the most commonly overexpressed oncogenes in breast cancer, with 45–50% of primary ductal carcinomas overexpressing this oncoprotein. Targeted deletion of the gene encoding cyclin D1 demonstrates an essential role in normal mammary gland development while transgenic studies provide evidence that cyclin D1 is a weak oncogene in mammary epithelium. In a recent exciting development, Yu et al. demonstrate that cyclin D1-deficient mice are resistant to mammary carcinomas induced by c-neu and v-Ha-ras, but not those induced by c-myc or Wnt-1. These findings define a pivotal role for cyclin D1 in a subset of mammary cancers in mice and imply a functional role for cyclin D1 overexpression in human breast cancer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=154565Documentos Relacionados
- Cyclin D1 expression in prostate carcinoma
- Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression
- Genetic Replacement of Cyclin D1 Function in Mouse Development by Cyclin D2
- Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.
- Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice.